Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM0HSJK)

Drug Name
FF-10501-01 Drug Info
Indication
Disease Entry ICD 11 Status REF
Acute myeloid leukaemia 2A60 Phase 1/2 [1]
Chronic myelogenous leukaemia 2A20.0 Phase 1/2 [1]
Haematological malignancy 2B33.Y Phase 1/2 [2]
Myelodysplastic syndrome 2A37 Phase 1/2 [1]
Cross-matching ID
PubChem CID
124343
TTD Drug ID
DM0HSJK

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cell differentiation (CD) TTF63Z1 NOUNIPROTAC Stimulator [1]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02193958) Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies. U.S. National Institutes of Health.